Founder & CEO - AI Pathology

FOUNDER & CEO — SLIDESTREAM Bringing high-quality pathology to the next billion patients Location: Bangalore (Bengaluru), India Start date: ASAP More about the concept here. https://docs.google.com/presentation/d/1QRTnTeCQr_LV5k1kmPCqdT9hcpoC53l1Roz1JYLnkYU/edit?slide=id.g3f5248405d1_0_0#slide=id.g3f5248405d1_0_0 Founders Factory builds and funds startups together with exceptional entrepreneurs and the world's leading companies. Created by IPO-exited founders, we offer founders capital, operational support from a team of hands-on experts, and unrivalled access to a coalition of industry-leading corporate partners. Since 2015, Founders Factory's 450+ portfolio companies have secured 500+ pilots and commercial contracts with our partners. Our Studio partners with entrepreneurs at day one, developing new ideas, technologies and business models into high-growth companies. In partnership with a leading global industrial technology partner, we are building a new portfolio of ventures. ABOUT THE VENTURE The blood smear is the frontline test for anaemia, leukaemia, infection and clotting disorders — a drop of blood read cell by cell under a microscope. In tier-2 and tier-3 India it is still read by eye, or often not at all. The reason is structural: Asia has 6.8 pathologists per million people versus 49 in North America, and fewer than 4 per million in much of Africa. The automated digital-morphology systems that could close the gap cost $50k+, out of reach for the small and mid-sized labs that need them, and labs without an on-site pathologist hand ~60% of every test fee to an outside reviewer — economics that only work at a volume they never reach. We are building Slidestream: a sub-€4k scanner, already designed and built by our partner, that photographs the slide, flags abnormal cells with on-board AI, and routes cases to a remote specialist — working offline, with no cloud dependency. The unfair advantage: our partner brings a cleared, low-cost prototype already built and CDSCO-cleared — trained on 5,000+ annotated data points with >80% accuracy on common morphologies, roughly two years of build already done — plus two decades of connected-device fleet management, an embedded compute and manufacturing cost base no medtech startup can match, and 35,000 engineers on the ground in Bengaluru for fast validation and distribution. Two independent investors ranked this concept their #1. OUR OFFER We don't just fund ideas — we co-build them. Join as Founder & CEO and get access to a full-stack venture studio offering designed to give you the best possible start: - €275k of spin-out capital plus a founder stipend + studio budget to build, validate, and launch - Expert Team: Hands-on support across product, growth, fundraising, AI/ML, design, legal, hiring, and more - MVP Build: Full-time venture builder(s) to help ship your first product - Accelerator: 6 months of deep operational support post-launch - Strategic Network: Intros to top-tier investors and corporate partners - Validation: A vetted concept, domain insight, and a head start in a massive market JOBS TO BE DONE As Founder & CEO, you will be responsible for turning a strong thesis into a scaled, defensible business. - Define the wedge. Decide the beachhead buyer — private tier-2/3 lab owner vs. government/NGO — and the pricing model (subscription vs. per-use) that gets to revenue fastest. - Take a ready asset to market. Turn the cleared scanner into paying deployments across Indian labs, validating the price point and per-test economics. - Build the network. Recruit and grow the pooled telepathology specialist network that turns a device into a defensible marketplace. - Win the first labs. Land a lighthouse cluster of labs and prove the sample-to-result loop in a single visit. - Leverage partner IP. Work with our partner's Bengaluru engineering and fleet-management teams on device economics, manufacturing scale and connected-fleet operations. - Build the company. Hire the initial